Rep. Bruce Westerman Sells Roche Holding AG (OTCMKTS:RHHBY) Shares

Representative Bruce Westerman (R-Arkansas) recently sold shares of Roche Holding AG OTCMKTS: RHHBY. In a filing disclosed on May 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Roche stock on April 21st. The trade occurred in the Representative's "FISHER IRA" account.

Representative Bruce Westerman also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Tokyo Electron OTCMKTS: TOELY on 4/21/2025.
• Sold $1,001 - $15,000 in shares of Anheuser-Busch InBev SA/NV NYSE: BUD on 4/21/2025.
• Sold $1,001 - $15,000 in shares of Meta Platforms NASDAQ: META on 4/21/2025.
• Sold $1,001 - $15,000 in shares of Edwards Lifesciences NYSE: EW on 4/21/2025.
• Sold $1,001 - $15,000 in shares of HSBC NYSE: HSBC on 4/21/2025.
• Sold $15,001 - $50,000 in shares of Apple NASDAQ: AAPL on 4/21/2025.
• Sold $1,001 - $15,000 in shares of DSV A/S OTCMKTS: DSDVY on 4/21/2025.
• Sold $1,001 - $15,000 in shares of Walmart NYSE: WMT on 4/21/2025.
• Sold $1,001 - $15,000 in shares of Bank of America NYSE: BAC on 4/21/2025.
• Sold $1,001 - $15,000 in shares of Thermo Fisher Scientific NYSE: TMO on 4/21/2025.

Roche Trading Up 1.6%

Shares of OTCMKTS RHHBY traded up $0.63 during midday trading on Friday, reaching $39.03. 1,891,819 shares of the company traded hands, compared to its average volume of 2,997,473. Roche Holding AG has a 52 week low of $31.19 and a 52 week high of $44.31. The stock has a 50-day moving average price of $40.04 and a 200 day moving average price of $38.60. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.26 and a quick ratio of 0.97.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the stock. Hsbc Global Res cut shares of Roche from a "strong-buy" rating to a "hold" rating in a research note on Monday, April 28th. Sanford C. Bernstein upgraded shares of Roche to a "strong-buy" rating in a research note on Thursday, January 30th. HSBC cut shares of Roche from a "buy" rating to a "hold" rating in a research note on Monday, April 28th. UBS Group upgraded shares of Roche from a "hold" rating to a "strong-buy" rating in a research note on Thursday, February 13th. Finally, Morgan Stanley initiated coverage on shares of Roche in a research note on Wednesday, February 12th. They set an "equal weight" rating on the stock. Two research analysts have rated the stock with a sell rating, three have given a hold rating, one has given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, Roche has an average rating of "Hold".

Institutional Investors Weigh In On Roche

Hedge funds and other institutional investors have recently bought and sold shares of the business. Brooklyn Investment Group increased its position in shares of Roche by 36.6% in the fourth quarter. Brooklyn Investment Group now owns 1,354 shares of the company's stock worth $48,000 after acquiring an additional 363 shares in the last quarter. Hantz Financial Services Inc. increased its position in shares of Roche by 0.9% in the fourth quarter. Hantz Financial Services Inc. now owns 33,708 shares of the company's stock worth $1,176,000 after acquiring an additional 305 shares in the last quarter. Verity Asset Management Inc. increased its position in shares of Roche by 26.8% in the fourth quarter. Verity Asset Management Inc. now owns 8,036 shares of the company's stock worth $280,000 after acquiring an additional 1,697 shares in the last quarter. Altrius Capital Management Inc increased its position in shares of Roche by 0.3% in the fourth quarter. Altrius Capital Management Inc now owns 183,448 shares of the company's stock worth $6,399,000 after acquiring an additional 603 shares in the last quarter. Finally, SVB Wealth LLC purchased a new position in shares of Roche in the fourth quarter worth approximately $555,000.

About Representative Westerman

Bruce Westerman (Republican Party) is a member of the U.S. House, representing Arkansas' 4th Congressional District. He assumed office on January 3, 2015. His current term ends on January 3, 2027. Westerman (Republican Party) is running for re-election to the U.S. House to represent Arkansas' 4th Congressional District. He declared candidacy for the 2026 election. Westerman earned his BSBAGE in biological and agricultural engineering from the University of Arkansas in 1990 and his MF in forestry from Yale University in 2001. His professional experience includes working as a plant engineer for Riceland Foods and an engineer/forester for Mid-South Engineering Company.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.